Recon: Pazdur reportedly intervened in Replimune decision; Eli Lilly to sell New Jersey facility

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States